Marijn E. Dekkers's most recent trade in Ginkgo Bioworks Holdings Inc - Ordinary Shares - Class A was a trade of 105,263 Restricted Stock Units done . Disclosure was reported to the exchange on June 12, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Ginkgo Bioworks Holdings I... | Marijn E. Dekkers | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jun 2024 | 105,263 | 0 | - | - | Restricted Stock Units | |
| Ginkgo Bioworks Holdings I... | Marijn E. Dekkers | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jun 2024 | 105,263 | 386,480 | - | - | Class A Common Stock | |
| Cerevel Therapeutics Holdi... | Marijn E. Dekkers | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 10,461 | 42,283 | - | - | Common Stock | |
| Ginkgo Bioworks Holdings I... | Marijn E. Dekkers | Director | Sale of securities on an exchange or to another person at price $ 0.83 per share. | 16 May 2024 | 265,000 | 5,515,364 | - | 0.8 | 220,030 | Class A Common Stock |
| Ginkgo Bioworks Holdings I... | Marijn E. Dekkers | Director | Sale of securities on an exchange or to another person at price $ 0.93 per share. | 14 May 2024 | 1,727,056 | 281,217 | - | 0.9 | 1,606,162 | Class A Common Stock |
| Ginkgo Bioworks Holdings I... | Marijn E. Dekkers | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2023 | 139,860 | 139,860 | - | - | Stock Option | |
| Ginkgo Bioworks Holdings I... | Marijn E. Dekkers | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2023 | 105,263 | 105,263 | - | - | Restricted Stock Units | |
| Cerevel Therapeutics Holdi... | Marijn E. Dekkers | Director | Sale of securities on an exchange or to another person at price $ 34.43 per share. | 15 Jun 2023 | 200,000 | 402,326 | - | 34.4 | 6,886,000 | Common Stock |
| Cerevel Therapeutics Holdi... | Marijn E. Dekkers | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2023 | 13,780 | 13,780 | - | - | Stock Option (Right to Buy) | |
| Cerevel Therapeutics Holdi... | Marijn E. Dekkers | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2023 | 3,282 | 31,822 | - | - | Common Stock | |
| Cerevel Therapeutics Holdi... | Marijn E. Dekkers | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Dec 2022 | 14,270 | 28,540 | - | 0 | Common Stock | |
| Ginkgo Bioworks Holdings I... | Marijn E. Dekkers | Director | Sale of securities on an exchange or to another person at price $ 2.56 per share. | 03 Nov 2022 | 171,455 | 2,021,132 | - | 2.6 | 438,925 | Class A Common Stock |
| Cerevel Therapeutics Holdi... | Marijn E. Dekkers | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2022 | 23,459 | 23,459 | - | - | Stock Option (Right to Buy) | |
| Ginkgo Bioworks Holdings I... | Marijn E. Dekkers | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2022 | 108,516 | 108,516 | - | - | Stock Option | |
| Ginkgo Bioworks Holdings I... | Marijn E. Dekkers | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2022 | 70,921 | 2,192,587 | - | 0 | Class A Common Stock | |
| Ginkgo Bioworks Holdings I... | Marijn E. Dekkers | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2022 | 1,746,706 | 2,121,666 | - | 0 | Class A Common Stock | |
| Cerevel Therapeutics Holdi... | Marijn E. Dekkers | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Sep 2021 | 14,270 | 0 | - | - | Restricted Stock Units | |
| Cerevel Therapeutics Holdi... | Marijn E. Dekkers | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Sep 2021 | 14,270 | 42,810 | - | - | Common Stock | |
| Ginkgo Bioworks Holdings I... | Marijn E. Dekkers | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Sep 2021 | 5,780,364 | 5,780,364 | - | - | Class A Common Stock | |
| Ginkgo Bioworks Holdings I... | Marijn E. Dekkers | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Sep 2021 | 374,960 | 374,960 | - | - | Class A Common Stock | |
| Cerevel Therapeutics Holdi... | Marijn E. Dekkers | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2021 | 58,003 | 58,003 | - | - | Stock Option (Right to Buy) | |
| Quanterix Corp | Marijn E. Dekkers | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Jan 2021 | 29,162 | 1,951 | - | - | Stock Option (right to buy) | |
| Quanterix Corp | Marijn E. Dekkers | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.16 per share. | 11 Jan 2021 | 29,162 | 54,042 (0%) | 0% | 8.2 | 237,962 | Common Stock |
| Quanterix Corp | Marijn E. Dekkers | Director | Sale of securities on an exchange or to another person at price $ 47.87 per share. | 11 Jan 2021 | 22,830 | 24,012 (0%) | 0% | 47.9 | 1,092,760 | Common Stock |
| Quanterix Corp | Marijn E. Dekkers | Director | Sale of securities on an exchange or to another person at price $ 51.08 per share. | 11 Jan 2021 | 8,199 | 9,080 (0%) | 0% | 51.1 | 418,822 | Common Stock |
| Quanterix Corp | Marijn E. Dekkers | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Jan 2021 | 7,900 | 0 | - | - | Stock Option (Right to Buy) | |
| Quanterix Corp | Marijn E. Dekkers | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Jan 2021 | 7,900 | 0 | - | - | Stock Option (Right to Buy) | |
| Quanterix Corp | Marijn E. Dekkers | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 14.80 per share. | 11 Jan 2021 | 7,900 | 24,880 (0%) | 0% | 14.8 | 116,920 | Common Stock |
| Quanterix Corp | Marijn E. Dekkers | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 18.24 per share. | 11 Jan 2021 | 7,900 | 16,980 (0%) | 0% | 18.2 | 144,096 | Common Stock |
| Quanterix Corp | Marijn E. Dekkers | Director | Sale of securities on an exchange or to another person at price $ 55.05 per share. | 11 Jan 2021 | 7,610 | 6,589 (0%) | 0% | 55.0 | 418,918 | Common Stock |
| Quanterix Corp | Marijn E. Dekkers | Director | Sale of securities on an exchange or to another person at price $ 47.17 per share. | 11 Jan 2021 | 7,200 | 46,842 (0%) | 0% | 47.2 | 339,592 | Common Stock |
| Quanterix Corp | Marijn E. Dekkers | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 23.12 per share. | 11 Jan 2021 | 4,732 | 11,321 (0%) | 0% | 23.1 | 109,404 | Common Stock |
| Quanterix Corp | Marijn E. Dekkers | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Jan 2021 | 4,732 | 0 | - | - | Stock Option (Right to Buy) | |
| Quanterix Corp | Marijn E. Dekkers | Director | Sale of securities on an exchange or to another person at price $ 56.24 per share. | 11 Jan 2021 | 4,691 | 2,270 (0%) | 0% | 56.2 | 263,845 | Common Stock |
| Quanterix Corp | Marijn E. Dekkers | Director | Sale of securities on an exchange or to another person at price $ 50.38 per share. | 11 Jan 2021 | 4,400 | 17,279 (0%) | 0% | 50.4 | 221,657 | Common Stock |
| Quanterix Corp | Marijn E. Dekkers | Director | Sale of securities on an exchange or to another person at price $ 55.58 per share. | 11 Jan 2021 | 4,360 | 6,961 (0%) | 0% | 55.6 | 242,315 | Common Stock |
| Quanterix Corp | Marijn E. Dekkers | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 23.12 per share. | 11 Jan 2021 | 3,168 | 14,199 (0%) | 0% | 23.1 | 73,244 | Common Stock |
| Quanterix Corp | Marijn E. Dekkers | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Jan 2021 | 3,168 | 4,732 | - | - | Stock Option (Right to Buy) | |
| Quanterix Corp | Marijn E. Dekkers | Director | Sale of securities on an exchange or to another person at price $ 49.16 per share. | 11 Jan 2021 | 2,333 | 21,679 (0%) | 0% | 49.2 | 114,682 | Common Stock |
| Quanterix Corp | Marijn E. Dekkers | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.16 per share. | 11 Jan 2021 | 1,951 | 11,031 (0%) | 0% | 8.2 | 15,920 | Common Stock |
| Quanterix Corp | Marijn E. Dekkers | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Jan 2021 | 1,951 | 0 | - | - | Stock Option (right to buy) | |
| Quanterix Corp | Marijn E. Dekkers | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2021 | 7,900 | 7,900 | - | - | Stock Option (Right to Buy) | |
| Quanterix Corp | Marijn E. Dekkers | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2021 | 2,270 | 9,080 (0%) | 0% | 0 | Common Stock | |
| Quanterix Corp | Marijn E. Dekkers | Director | Sale of securities on an exchange or to another person at price $ 32.49 per share. | 07 Aug 2020 | 27,619 | 0 (0%) | 0% | 32.5 | 897,341 | Common Stock |